이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Xiangxue PharmaceuticalLtd 관리

관리 기준 확인 3/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Yonghui Wang

최고 경영자

CN¥900.0k

총 보상

CEO 급여 비율	n/a
CEO 임기	14.3yrs
CEO 소유권	n/a
경영진 평균 재임 기간	2.3yrs
이사회 평균 재임 기간	5.3yrs

최근 관리 업데이트

Recent updates

CEO

Yonghui Wang (62 yo)

14.3yrs

테뉴어

CN¥900,000

보상

Mr. Yonghui Wang serves as General Manager and Chairman of Xiangxue Pharmaceutical Co., Ltd. since July 23, 2010. Mr. Wang served as Deputy General Manager of Guangzhou Wanbao Group Industrial Washing Mach...

리더십 팀

이름	위치	테뉴어	보상	소유권
Yonghui Wang	Chairman & GM	14.3yrs	CN¥900.00k	데이터 없음
Xiaoyan Niu	Financial Director	2.3yrs	CN¥360.00k	0.0023% CN¥ 125.6k
Li Xu	Secretary of the Board of Directors & Non-Independent Director	no data	CN¥240.00k	0.030% CN¥ 1.7m
Lun Zeng	Vice President	no data	CN¥960.00k	0.060% CN¥ 3.3m
Guanghua Tan	General Manager of Marketing Center	2.3yrs	CN¥530.00k	0.039% CN¥ 2.2m
Zhiying Kang	GM of Technology R&D	no data	CN¥240.00k	0.046% CN¥ 2.6m
Feng Lu	Director of Internal Audit	2.3yrs	CN¥180.00k	0.037% CN¥ 2.0m
Junliang Zhong	Supply Chain General Manager	2.3yrs	CN¥263.00k	데이터 없음

2.3yrs

평균 재임 기간

49yo

평균 연령

경험이 풍부한 관리: 300147 의 관리팀은 경험 ( 2 년 평균 재직 기간)으로 간주됩니다.

이사회 구성원

이름	위치	테뉴어	보상	소유권
Yonghui Wang	Chairman & GM	14.3yrs	CN¥900.00k	데이터 없음
Li Xu	Secretary of the Board of Directors & Non-Independent Director	5.3yrs	CN¥240.00k	0.030% CN¥ 1.7m
Wen Jin Chen	Director	2.3yrs	CN¥240.00k	0.0091% CN¥ 502.0k
Zi Yu Mo	Non-Employee Representative Supervisor	8.4yrs	CN¥320.00k	0.027% CN¥ 1.5m
Wen Hui Tan	Non-Independent Director	14.3yrs	데이터 없음	0.020% CN¥ 1.1m
Jun Hui Chen	Non-Employee Representative Supervisor	8.4yrs	데이터 없음	데이터 없음
Qingquan Zhou	Independent Director	5.3yrs	CN¥60.00k	데이터 없음
Jianhong Tao	Independent Director	3.2yrs	CN¥60.00k	데이터 없음
Jie Wu	Independent Director	3.2yrs	CN¥60.00k	데이터 없음
Wei Hua Huang	Chairman of the Supervisory Board	5.3yrs	CN¥280.00k	0.028% CN¥ 1.6m

5.3yrs

평균 재임 기간

57yo

평균 연령

경험이 풍부한 이사회: 300147 의 이사회는 경험(평균 재직 기간 5 년)으로 간주됩니다.

Xiangxue PharmaceuticalLtd 관리

관리 기준 확인 3/4

주요 정보

최근 관리 업데이트

Xiangxue Pharmaceutical Co.,Ltd., Annual General Meeting, Jun 07, 2024

Xiangxue Pharmaceutical Co.,Ltd., Annual General Meeting, Jun 30, 2023

Insufficient new directors

Xiangxue Pharmaceutical Co.,Ltd. Approves Board Elections

Xiangxue Pharmaceutical Co.,Ltd., Annual General Meeting, Jun 24, 2022

Recent updates

Xiangxue Pharmaceutical Co.,Ltd. to Report Q3, 2024 Results on Oct 26, 2024

Second quarter 2024 earnings released: CN¥0.16 loss per share (vs CN¥0.081 loss in 2Q 2023)

Xiangxue Pharmaceutical Co.,Ltd. to Report First Half, 2024 Results on Aug 29, 2024

Xiangxue Pharmaceutical Co.,Ltd., Annual General Meeting, Jun 07, 2024

Full year 2023 earnings released: CN¥0.59 loss per share (vs CN¥0.81 loss in FY 2022)

Xiangxue Pharmaceutical Co.,Ltd. to Report Q1, 2024 Results on Apr 29, 2024

New minor risk - Share price stability

Xiangxue Pharmaceutical Co.,Ltd. to Report Fiscal Year 2023 Results on Apr 27, 2024

Third quarter 2023 earnings released: CN¥0.12 loss per share (vs CN¥0.19 loss in 3Q 2022)

Second quarter 2023 earnings released: CN¥0.081 loss per share (vs CN¥0.18 loss in 2Q 2022)

Xiangxue Pharmaceutical Co.,Ltd. announced that it expects to receive CNY 959.884 million in funding

New major risk - Financial position

Xiangxue Pharmaceutical Co.,Ltd., Annual General Meeting, Jun 30, 2023

Full year 2022 earnings released: CN¥0.81 loss per share (vs CN¥1.04 loss in FY 2021)

Third quarter 2022 earnings released: CN¥0.19 loss per share (vs CN¥0.077 loss in 3Q 2021)

Second quarter 2022 earnings released: CN¥0.18 loss per share (vs CN¥0.04 profit in 2Q 2021)

Insufficient new directors

Xiangxue Pharmaceutical Co.,Ltd. Approves Board Elections

Xiangxue Pharmaceutical Co.,Ltd., Annual General Meeting, Jun 24, 2022

Full year 2021 earnings released: CN¥1.04 loss per share (vs CN¥0.15 profit in FY 2020)

Third quarter 2021 earnings released: CN¥0.077 loss per share (vs CN¥0.01 profit in 3Q 2020)

First quarter 2021 earnings released: EPS CN¥0.04 (vs CN¥0.12 in 1Q 2020)

Xiangxue Pharmaceutical Co.,Ltd. to Report Fiscal Year 2020 Results on Apr 10, 2021

New 90-day low: CN¥8.31

New 90-day low: CN¥8.83

New 90-day low: CN¥9.90

Third quarter earnings released

New 90-day high: CN¥12.89

Market bids up stock over the past week

Xiangxue Pharmaceutical Co.,Ltd. to Report Q3, 2020 Results on Oct 24, 2020

111, Inc. and Guangzhou Xiangxue Pharmaceutical Co., Ltd. Officially Sign Strategic Partnership Agreement

New 90-day high - CN¥11.96

First half earnings released

Xiangxue Pharmaceutical Co.,Ltd. to Report First Half, 2020 Results on Aug 28, 2020

CEO

테뉴어

보상

리더십 팀

평균 재임 기간

평균 연령

이사회 구성원

평균 재임 기간

평균 연령